Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Communicable Chronic Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07537387
What this trial is testing

A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha

Who this might be right for
Chronic Hepatitis b
xieqing 10,000
Large-scale testing (Phase 3)Study completedNCT01195246
What this trial is testing

Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on Hemodialysis

Who this might be right for
End Stage Renal Disease
Dynavax Technologies Corporation 155
Not applicableLooking for participantsNCT02863757
What this trial is testing

Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease

Who this might be right for
Chronic Hepatitis BNonalcoholic Fatty Liver Disease
Humanity and Health Research Centre 1,500
Post-approval studies (Phase 4)UnknownNCT04069858
What this trial is testing

Maintaining Antiviral Efficacy After Switching to Generic Entecavir 1 mg for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Korea University 40
Large-scale testing (Phase 3)Study completedNCT01979939
What this trial is testing

UNITY 1: A Study of an Investigational Treatment Regimen of Daclatasvir (DCV) + Asunaprevir (ASV) + BMS-791325 in a Fixed Dose Combination (the DCV 3DAA (Direct Acting Antiviral) Regimen) for 12 Weeks for the Treatment of Chronic Hepatitis C Virus (HCV) Genotype 1 Infection in Non-cirrhotic Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 416
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Not applicableStudy completedNCT01579162
What this trial is testing

Intra-Individual Reproducibility of the Non-Invasive Assessment of the Portal Circulation

Who this might be right for
Hepatitis C, ChronicNon-Alcoholic Fatty Liver Disease
HepQuant, LLC 48
Post-approval studies (Phase 4)Study completedNCT06000657
What this trial is testing

Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir

Who this might be right for
Hepatitis B, Chronic
Daewoong Pharmaceutical Co. LTD. 196
Not applicableUnknownNCT04039698
What this trial is testing

Monitoring of Hepatitis C Treatment Using Telemedicine - a Clinical Trial in Public Health System in Brazil

Who this might be right for
Chronic Hepatitis C
Hospital de Clinicas de Porto Alegre 144
Large-scale testing (Phase 3)UnknownNCT02991638
What this trial is testing

Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers

Who this might be right for
Chronic Lymphocytic LeukemiaIndolent B-cell LymphomasChronic Hepatitis B+4 more
The University of Hong Kong 62
Large-scale testing (Phase 3)Study completedNCT00323804
What this trial is testing

Interest of Ribavirin in the Maintenance Treatment of Liver Fibrosis Using Low Dose Pegylated Interferon alpha2b in Patients With Chronic Hepatitis C Non Responders to Previous Antiviral Therapy.

Who this might be right for
Hepatitis C, ChronicLiver Fibrosis
ANRS, Emerging Infectious Diseases 372
Large-scale testing (Phase 3)Study completedNCT02723084
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus Infection

Who this might be right for
Chronic Hepatitis C VirusHepatitis C Virus
AbbVie 136
Large-scale testing (Phase 3)Study completedNCT00310336
What this trial is testing

Chronic Hepatitis C Non-Responder Study With AdoMet and Betaine

Who this might be right for
Hepatitis C
University Hospital, Basel, Switzerland 30
Testing effectiveness (Phase 2)Study completedNCT00199719
What this trial is testing

Study of the Pharmacokinetic Action of Amantadine and Ribavirin in Chronic Hepatitis C. CINAM

Who this might be right for
Chronic Hepatitis C
University Hospital, Limoges 30
Not applicableStudy completedNCT05122832
What this trial is testing

Prevalence of NCD Risk Factors in Kazakhstan

Who this might be right for
Non-Communicable Chronic Diseases
Asfendiyarov Kazakh National Medical University 20,400
Testing effectiveness (Phase 2)UnknownNCT06566248
What this trial is testing

A Clinical Trial to Evaluate the Efficacy and Safety of TQA3810 Tablets in Combination/Non Combination With Nucleoside (Acid) Analogues in Patients With Primary/Treated Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 90
Not applicableUnknownNCT01545544
What this trial is testing

Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)

Who this might be right for
Chronic Hepatitis C
ANRS, Emerging Infectious Diseases 138
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableStudy completedNCT01667432
What this trial is testing

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 141
Next Page